Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Obeticholic acid placebo
DRUG
2 trials
Sponsors
Sahlgrenska University Hospital
, Intercept Pharmaceuticals
Conditions
Obesity
Primary Biliary Cholangitis
Phase 1
Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers
NCT02532335
Sahlgrenska University Hospital
Obesity
Start: 2015-08-31
End: 2021-06-30
Target: 40
Updated: 2020-08-25
Phase 2
Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC
Completed
NCT05239468
Intercept Pharmaceuticals
Primary Biliary Cholangitis
Start: 2022-03-21
End: 2025-09-01
Updated: 2025-09-25